Cargando...
Integrating Transcriptomic Data with Mechanistic Systems Pharmacology Models for Virtual Drug Combination Trials
Monotherapy clinical trials with mutation-targeted kinase inhibitors, despite some success in other cancers, have yet to impact glioblastoma (GBM). Besides insufficient blood-brain-barrier penetration, combinations are key to overcoming obstacles such as intratumoral heterogeneity, adaptive resistan...
Guardado en:
| Publicado en: | ACS Chem Neurosci |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5771884/ https://ncbi.nlm.nih.gov/pubmed/28950062 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acschemneuro.7b00197 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|